Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and split thickness skin grafting under adequate immunosuppression is a valuable treatment option: Case series of 15 patients.
| Publicado en: | Journal of the American Academy of Dermatology Vol. 74; no. 4; pp. 760 - 766 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Elsevier B.V.
Apr2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=113724427&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 113724427 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01909622 1ZF jtl: Journal of the American Academy of Dermatology issn: 01909622 maglogo: N pubinfo: dt: Apr2016 vid: 74 iid: 4 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 113724427 113724427 NLM26979359 10.1016/j.jaad.2015.09.009 NLM26979359 113724427 ppf: 760 ppct: 6 formats: tig: atl: Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and split thickness skin grafting under adequate immunosuppression is a valuable treatment option: Case series of 15 patients. aug: au: Pichler, Maria Larcher, Lorenz Holzer, Michael Exler, Gerald Thuile, Tobias Gatscher, Barbara Tappeiner, Lukas Deluca, Jenny Carriere, Cinzia Nguyen, Van Anh Moosbrugger-Martinz, Verena Schmuth, Matthias Klein, Georg F. Eisendle, Klaus affil: Department of Dermatology, Venereology and Allergology, Academic Teaching Department of Medical University Innsbruck, Central Teaching Hospital Bolzano/Bozen, Bolzano/Bozen, Italy sug: subj: Pyoderma Gangrenosum Therapy Immunosuppressive Agents Therapeutic Use Pyoderma Gangrenosum Diagnosis Negative Pressure Wound Therapy Methods Skin Transplantation Methods Female Severity of Illness Indices Recurrence Probability Sample Risk Assessment Wound Healing Physiology Treatment Outcomes Adult Middle Age Skin Transplantation Adverse Effects Prospective Studies Combined Modality Therapy Aged Disease Attributes Male Adult: 19-44 years Middle Aged: 45-64 years Aged: 65+ years Female Male pubtype: Academic Journal doctype: Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|